In contrast, among dMMR/MSI colorectal cancers, the GALNT7-Low subset exhibits high levels of tumor cell PD-L1 and poor prognosis, highlighting the need for more intensive therapeutic strategies beyond current clinical practice. This evidence concerns the gene GALNT7 and colorectal cancer.